BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19760044)

  • 1. Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.
    Cayo AK; Sippel RS; Schaefer S; Chen H
    Ann Surg Oncol; 2009 Dec; 16(12):3450-4. PubMed ID: 19760044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.
    Heller KS; Blumberg SN
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging.
    Barczynski M; Konturek A; Cichon S; Hubalewska-Dydejczyk A; Golkowski F; Huszno B
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):878-85. PubMed ID: 17437518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the final intraoperative PTH level really have to fall into the normal range to signify cure?
    Reiher AE; Schaefer S; Chen H; Sippel RS
    Ann Surg Oncol; 2012 Jun; 19(6):1862-7. PubMed ID: 22203183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism.
    Yen TW; Wilson SD; Krzywda EA; Sugg SL
    Surgery; 2006 Oct; 140(4):665-72; discussion 672-4. PubMed ID: 17011915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate and medium-term results of intraoperative parathyroid hormone monitoring during video-assisted parathyroidectomy.
    Maweja S; Sebag F; Hubbard J; Giorgi R; Henry JF
    Arch Surg; 2004 Dec; 139(12):1301-3. PubMed ID: 15611454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT).
    Karakousis GC; Han D; Kelz RR; Nemani D; Karamacharya J; Roses R; Gimotty PA; Fraker DL
    Surgery; 2007 Dec; 142(6):845-50; discussion 850.e1-2. PubMed ID: 18063066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome.
    Lew JI; Irvin GL
    Surgery; 2009 Dec; 146(6):1021-7. PubMed ID: 19879612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma.
    Kandil E; Alabbas HH; Bansal A; Islam T; Tufaro AP; Tufano RP
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1206-8. PubMed ID: 20026817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explanation.
    Westerdahl J; Bergenfelz A
    Arch Surg; 2006 Jun; 141(6):589-94. PubMed ID: 16785360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring.
    Richards ML; Thompson GB; Farley DR; Grant CS
    Am J Surg; 2008 Dec; 196(6):937-42; discussion 942-3. PubMed ID: 19095113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative parathyroid hormone assay: a necessary tool for multiglandular disease.
    Gill MT; Dean M; Karr J; Aultman DF; Nathan CO
    Otolaryngol Head Neck Surg; 2011 May; 144(5):691-7. PubMed ID: 21493339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success.
    Weber KJ; Misra S; Lee JK; Wilhelm SW; DeCresce R; Prinz RA
    Surgery; 2004 Dec; 136(6):1154-9. PubMed ID: 15657570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-operative parathyroid hormone kinetics and influencing factors with high baseline PTH: a prospective study.
    Singh DN; Gupta SK; Chand G; Mishra A; Agarwal G; Verma AK; Mishra SK; Shukla M; Agarwal A
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):935-41. PubMed ID: 23046058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately?
    Wachtel H; Cerullo I; Bartlett EK; Kelz RR; Karakousis GC; Fraker DL
    Ann Surg Oncol; 2015; 22(6):1781-8. PubMed ID: 25354574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identified.
    Ahmed K; Alhefdhi A; Schneider DF; Ojomo KA; Sippel RS; Chen H; Mazeh H
    Ann Surg Oncol; 2013 Dec; 20(13):4200-4. PubMed ID: 23943032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of intraoperative parathyroid hormone monitoring.
    Sharma J; Milas M; Berber E; Mazzaglia P; Siperstein A; Weber CJ
    Ann Surg Oncol; 2008 Feb; 15(2):493-8. PubMed ID: 18026797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy.
    Mazeh H; Chen H; Leverson G; Sippel RS
    Ann Surg; 2013 Jan; 257(1):138-41. PubMed ID: 22801087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL.
    Miller BS; England BG; Nehs M; Burney RE; Doherty GM; Gauger PG
    Surgery; 2006 Dec; 140(6):883-9; discussion 889-90. PubMed ID: 17188134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring.
    Hundley JC; Woodrum DT; Saunders BD; Doherty GM; Gauger PG
    Surgery; 2005 Dec; 138(6):1027-31; discussion 1031-2. PubMed ID: 16360387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.